2020 Vitiligo International Symposium – John E. Harris, MD, PhD

Director, Vitiligo Clinic and Research Center

Chair Designate, Department of Dermatology

University of Massachusetts Medical School and UMass/Memorial Hospital

Worcester, MA  USA


Advances in Immune Mechanisms of Vitiligo


Recent advances in understanding the immune mechanisms of vitiligo are leading to new treatments for the disease. Current strategies include inhibiting T cell function and migration to the skin, as well as long-term survival of autoreactive memory T cells. An advanced understanding of cellular signaling within vitiligo lesions may lead to more advanced therapeutic approaches in the future.